-Reuters
Oramed Subsidiary Oravax Announces First Participant Enrolled In Phase 1 Oral COVID-19 Vaccine Trial In South Africa
=
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, announced today that its subsidiary, Oravax